• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脆弱双核阿米巴感染是儿童胃肠道症状的一个病因。

Dientamoeba fragilis infection, a cause of gastrointestinal symptoms in childhood.

作者信息

Preiss U, Ockert G, Brömme S, Otto A

机构信息

Klinik und Poliklinik für Kinderheilkunde des Bereiches Medizin, Martin-Luther-Universität Halle-Wittenberg.

出版信息

Klin Padiatr. 1990 Mar-Apr;202(2):120-3. doi: 10.1055/s-2007-1025503.

DOI:10.1055/s-2007-1025503
PMID:2325352
Abstract

Clinical and laboratory findings of 123 paediatric patients with infections due to intestinal protozoa were analysed. Dientamoeba fragilis (D.f.) was found in 102 cases. The other patients had infections with Giardia lamblia or mixed infections with several other protozoa. Acute and recurrent diarrhoea were the most common findings (56 cases), whereas abdominal pain was more common in children with chronic symptoms. Peripheral eosinophilia was present in 32% of the children with dientamoebiasis. Metronidazole, oxytetracycline, doxycycline, and erythromycin were the most effective drugs in the treatment of D.f. infections. The therapy led coincidentally to the sanitation of stools and elimination of abdominal complaints. The investigations underline the pathogenic role of D.f. in those children with gastrointestinal symptoms. Mixed infections of D.f. and Enterobius vermicularis suggest a vector bound transmission of D.f.

摘要

对123例肠道原生动物感染的儿科患者的临床和实验室检查结果进行了分析。在102例患者中发现了脆弱双核阿米巴(D.f.)。其他患者感染了蓝氏贾第鞭毛虫或合并感染了其他几种原生动物。急性和复发性腹泻是最常见的症状(56例),而腹痛在有慢性症状的儿童中更为常见。32%的双核阿米巴病患儿外周血嗜酸性粒细胞增多。甲硝唑、土霉素、强力霉素和红霉素是治疗D.f.感染最有效的药物。该治疗同时使粪便卫生状况得到改善,并消除了腹部不适。这些研究强调了D.f.在有胃肠道症状儿童中的致病作用。D.f.与蠕形住肠线虫的混合感染提示D.f.存在媒介传播。

相似文献

1
Dientamoeba fragilis infection, a cause of gastrointestinal symptoms in childhood.脆弱双核阿米巴感染是儿童胃肠道症状的一个病因。
Klin Padiatr. 1990 Mar-Apr;202(2):120-3. doi: 10.1055/s-2007-1025503.
2
On the clinical importance of Dientamoeba fragilis infections in childhood.关于脆弱双核阿米巴感染在儿童期的临床重要性
J Hyg Epidemiol Microbiol Immunol. 1991;35(1):27-34.
3
Clinical and microbiological features of dientamoebiasis in patients suspected of suffering from a parasitic gastrointestinal illness: a comparison of Dientamoeba fragilis and Giardia lamblia infections.疑似患有寄生虫性胃肠道疾病患者的肠滴虫病的临床和微生物学特征:脆弱双核阿米巴与蓝氏贾第鞭毛虫感染的比较
Int J Infect Dis. 2006 May;10(3):255-61. doi: 10.1016/j.ijid.2005.05.011. Epub 2006 Feb 15.
4
[Dientamoeba fragilis: possibly an important cause of persistent abdominal pain in children].脆弱双核阿米巴:可能是儿童持续性腹痛的一个重要原因
Ned Tijdschr Geneeskd. 2004 Mar 20;148(12):575-9.
5
[Human intestinal parasitosis: role of Dientamoeba fragilis in human infections].[人体肠道寄生虫病:脆弱双核阿米巴在人类感染中的作用]
Ann Ig. 2007 Jan-Feb;19(1):27-34.
6
Transmission of Dientamoeba fragilis: evaluation of the role of Enterobius vermicularis.脆弱双核阿米巴的传播:蛲虫作用的评估
Parasitol Int. 2008 Mar;57(1):72-5. doi: 10.1016/j.parint.2007.09.001. Epub 2007 Sep 14.
7
[Dientamoeba fragilis and dientamoebiasis: aspects of clinical parasitology and laboratory diagnosis].[脆弱双核阿米巴与双核阿米巴病:临床寄生虫学与实验室诊断方面]
Parassitologia. 2001 Sep;43(3):135-8.
8
Dientamoeba fragilis. An intestinal pathogen in children?
Am J Dis Child. 1979 Apr;133(4):390-3.
9
Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis.肠易激综合征:关于肠道原生动物的作用及其检测与诊断重要性的综述
Int J Parasitol. 2007 Jan;37(1):11-20. doi: 10.1016/j.ijpara.2006.09.009. Epub 2006 Oct 12.
10
A case-controlled study of Dientamoeba fragilis infections in children.一项关于儿童脆弱双核阿米巴感染的病例对照研究。
Parasitology. 2011 Jun;138(7):819-23. doi: 10.1017/S0031182011000448. Epub 2011 Apr 27.

引用本文的文献

1
Prevalence of sp. among cooks in the region of Fez-Meknes (Morocco).非斯-梅克内斯地区(摩洛哥)厨师中sp. 的患病率。
Helminthologia. 2023 Jun 4;60(1):36-43. doi: 10.2478/helm-2023-0002. eCollection 2023 Mar.
2
Treatment of : A retrospective Finnish analysis of faecal clearance and clinical cure comparing four antiprotozoal drugs.治疗:一项芬兰的回顾性分析,比较四种抗原生动物药物的粪便清除率和临床治愈率。
New Microbes New Infect. 2023 Sep 23;54:101179. doi: 10.1016/j.nmni.2023.101179. eCollection 2023 Sep.
3
Prevalence of Intestinal Parasitoses in a Non-Endemic Setting during a 10-Year Period (2011-2020): A Focus on .
10年期间(2011 - 2020年)非流行地区肠道寄生虫病的患病率:聚焦于……
Microorganisms. 2022 Feb 12;10(2):426. doi: 10.3390/microorganisms10020426.
4
Investigation of neglected protists Blastocystis sp. and Dientamoeba fragilis in immunocompetent and immunodeficient diarrheal patients using both conventional and molecular methods.采用常规和分子方法调查免疫功能正常和免疫功能低下的腹泻患者中被忽视的原生动物 Blastocystis sp. 和 Dientamoeba fragilis。
PLoS Negl Trop Dis. 2021 Oct 6;15(10):e0009779. doi: 10.1371/journal.pntd.0009779. eCollection 2021 Oct.
5
Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment.巴龙霉素优于甲硝唑治疗脆弱双核阿米巴。
Int J Parasitol Drugs Drug Resist. 2019 Dec;11:95-100. doi: 10.1016/j.ijpddr.2019.10.005. Epub 2019 Nov 11.
6
Comparison and Recommendations for Use of Dientamoeba fragilis Real-Time PCR Assays.脆弱双核阿米巴实时 PCR 检测方法的比较与使用建议。
J Clin Microbiol. 2019 Apr 26;57(5). doi: 10.1128/JCM.01466-18. Print 2019 May.
7
Does Dientamoeba fragilis cause diarrhea? A systematic review.脆弱双核阿米巴会引发腹泻吗?一项系统综述。
Parasitol Res. 2018 Apr;117(4):971-980. doi: 10.1007/s00436-018-5771-4. Epub 2018 Feb 5.
8
Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel.脆弱双核阿米巴,被忽视的人体肠道毛滴虫。
Clin Microbiol Rev. 2016 Jul;29(3):553-80. doi: 10.1128/CMR.00076-15.
9
Dientamoeba fragilis, One of the Neglected Intestinal Protozoa.脆弱双核阿米巴,一种被忽视的肠道原生动物。
J Clin Microbiol. 2016 Sep;54(9):2243-50. doi: 10.1128/JCM.00400-16. Epub 2016 Apr 6.
10
Molecular testing for clinical diagnosis and epidemiological investigations of intestinal parasitic infections.用于肠道寄生虫感染临床诊断和流行病学调查的分子检测
Clin Microbiol Rev. 2014 Apr;27(2):371-418. doi: 10.1128/CMR.00122-13.